<DOC>
	<DOCNO>NCT01740921</DOCNO>
	<brief_summary>Some gut hormone , call incretins , stimulate insulin production order control sugar level also activate brain centre signal stop eating . Current administration incretin-based therapy mimic gut hormone subcutaneous ( skin ) injection routinely available diabetic patient 4 year . It effective treatment lower blood glucose average weight loss 3-4kg.Recent evidence , animal study limit human study , suggest incretins base treatment may also beneficial effect blood vessel function . However , know whether effect direct action blood vessel independent improvement latent inflammation typically associated weight loss anti-inflammatory effect incretin treatment . The aim study determine whether incretin-based diabetes treatment GLP-1 ( Glucagon-like peptide 1 ) analogue Liraglutide ( also know Victoza ) , mimic action incretins , improve blood vessel function individual type 2 diabetes . It determine whether improvement blood vessel function independent effect weight loss change inflammation . This study vascular function 4 month Victoza treatment subject Type 2 diabetes comparison 1 ) participant randomize hypo-caloric diet achieve similar weight loss Victoza 2 ) participant randomize treatment daily aspirin . Comprehensive assessment blood vessel function , body fat distribution metabolic profile baseline end treatment phase combine assessment inflammation marker blood fat tissue biopsy .</brief_summary>
	<brief_title>GLP-1 Microvascular Function Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Type 2 diabetes HbA1C 78.5 % stable dose sulphonylurea and/or metformin use insulin corticosteroid contraceptive , tamoxifen methotrexate DPPIV inhibitor pregnancy lactation endocrine disorder acute MI cerebrovascular disease Raynaud 's disease connective tissue disease current previous history malignancy subject treat ergotamine derivative unstable blood pressure last 3 month current treatment warfarin subject antiinflammatory antiplatelet agent history bleed disorder GI bleeds .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>GLP-1 analogue</keyword>
	<keyword>microvascular</keyword>
	<keyword>inflammation</keyword>
	<keyword>fat tissue</keyword>
	<keyword>clot structure</keyword>
</DOC>